KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Other Non-Current Liabilities (2016 - 2025)

BeOne Medicines (ONC) has disclosed Other Non-Current Liabilities for 11 consecutive years, with $64.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Liabilities changed N/A to $64.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $64.1 million, a N/A change, with the full-year FY2024 number at $66.7 million, down 61.12% from a year prior.
  • Other Non-Current Liabilities was $64.1 million for Q3 2025 at BeOne Medicines, down from $65.6 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $180.5 million in Q4 2022 to a low of $54.2 million in Q4 2021.
  • A 5-year average of $93.9 million and a median of $65.6 million in 2025 define the central range for Other Non-Current Liabilities.
  • Peak YoY movement for Other Non-Current Liabilities: surged 232.77% in 2022, then crashed 61.12% in 2024.
  • BeOne Medicines' Other Non-Current Liabilities stood at $54.2 million in 2021, then soared by 232.77% to $180.5 million in 2022, then fell by 4.89% to $171.6 million in 2023, then plummeted by 61.12% to $66.7 million in 2024, then decreased by 4.01% to $64.1 million in 2025.
  • Per Business Quant, the three most recent readings for ONC's Other Non-Current Liabilities are $64.1 million (Q3 2025), $65.6 million (Q1 2025), and $66.7 million (Q4 2024).